Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

The role of procoagulant activity in patients with community acquired pneumonia

Alona Matveychuk, Masri Numan, Alexander Guber, Baruch Chen, David Shitrit
European Respiratory Journal 2012 40: P1738; DOI:
Alona Matveychuk
1Pulmonary Department, Meir Medical Center, Kfar Saba, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masri Numan
1Pulmonary Department, Meir Medical Center, Kfar Saba, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Guber
1Pulmonary Department, Meir Medical Center, Kfar Saba, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baruch Chen
1Pulmonary Department, Meir Medical Center, Kfar Saba, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Shitrit
1Pulmonary Department, Meir Medical Center, Kfar Saba, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Community acquired pneumonia (CAP) is still one of the most important causes of morbidity in adults. In severe cases, parapneumonic effusions or empyema may develop. In these patients, the increased vascular permeability, mediated by several cytokines, allows migration of inflammatory cells, an increased fluid accumulation and bacterial invasion into pleural space. The activation of the fibrinolytic system produce the D-dimer and follow by increased other procoagulant markers like thrombin anti thrombin (TAT), fragment 1.2. Moreover, serum levels of AT-III, D-D and CRP at admission appear to be useful biomarkers for assessing the severity of CAP. Our study included patients with CAP. Blood D-dimer, TAT and Fragment 1,2 levels were measured by Enzyme Linked Fluorescent assay 24 and 48 hours after admission. The results were correlated with the clinical, laboratory, and severity scoring of pneumonia (PORT and APACHI II). A total of 59 patients with pleural effusion were included in the study. Eleven patients (18%) developed pleural effusion. Only D-dimer levels increased 48 hours following admission compared to the 24 hours levels (1939±1234 vs 1812±1592 ng/ml). Fragment 1,2 and TAT levels decreased after 48 hours. D-dimer at 24 hours was correlated with the age, platelet counts and PORT score. F 1,2 and TAT at 24 hours were correlated with recent of neutrophils. PT at 24 hours was correlated with WBC count. After 48 hours, D-dimer was correlated only with age. F1,2 and TAT had no correlations with clinical parameters after 48 hours. The 24 hours D-dimer predicts severity of CAP. Other coagulation markers and serial monitoring of blood coagulation markers have a limited role in predicting CAP.

  • Pneumonia
  • Biomarkers
  • Adolescents
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of procoagulant activity in patients with community acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The role of procoagulant activity in patients with community acquired pneumonia
Alona Matveychuk, Masri Numan, Alexander Guber, Baruch Chen, David Shitrit
European Respiratory Journal Sep 2012, 40 (Suppl 56) P1738;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The role of procoagulant activity in patients with community acquired pneumonia
Alona Matveychuk, Masri Numan, Alexander Guber, Baruch Chen, David Shitrit
European Respiratory Journal Sep 2012, 40 (Suppl 56) P1738;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Healthcare worker influenza vaccination is associated with reduced rates of sickness absence
  • Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study
  • Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance
Show more 10.1 Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society